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Original ArticleRegulation of glucose uptake and inﬂammation
markers by FOXO1 and FOXO3 in skeletal muscleLeonidas S. Lundell 1, Julie Massart 2, Ali Altıntas¸ 3, Anna Krook 1,2, Juleen R. Zierath 1,2,3,*ABSTRACT
Objective: Forkhead box class O (FOXO) transcription factors regulate whole body energy metabolism, skeletal muscle mass, and substrate
switching. FOXO1 and FOXO3 are highly abundant transcription factors, but their precise role in skeletal muscle metabolism has not been fully
elucidated.
Methods: To elucidate the role of FOXO in skeletal muscle, dominant negative (dn) constructs for FOXO1 (FOXO1dn) or FOXO3 (FOXO3dn) were
transfected by electroporation into mouse tibialis anterior muscle and glucose uptake, signal transduction, and gene expression proﬁles were
assessed after an oral glucose tolerance test. Results were compared against contralateral control transfected muscle.
Results: FOXO1dn and FOXO3dn attenuated glucose uptake (35%, p < 0.01 and 20%, p < 0.05), GLUT4 protein (40%, p < 0.05 and 10%,
p< 0.05), and subunits of the oxidative phosphorylation cascade. Intramuscular glycogen content was decreased (20%, p< 0.05) by FOXO3dn,
but not FOXO1dn. Transcriptomic analysis revealed major pathways affected by FOXO1dn or FOXO3dn revolve around metabolism and
inﬂammation. FOXO1dn increased Akt protein (140%, p < 0.001), p-AktSer473 (720%, p < 0.05) and p-AktThr308 (570%, p < 0.01), whereas
FOXO3dn was without effect. FOXO1dn and FOXO3dn increased mTOR protein content (170% and 190%, p< 0.05), and p-p70S6KThr389 (420%,
p< 0.01 and 300%, p< 0.01), while p-mTORSer2448 (500%, p< 0.01), was only increased by FOXO1dn. Chemokines and immune cell markers
were robustly upregulated in skeletal muscle following the FOXOdn transfections, but not after control transfection.
Conclusions: FOXO1 and FOXO3 regulate glucose metabolism and markers of inﬂammation in skeletal muscle, implicating transcriptional
control governing “immunometabolic” dynamics.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Skeletal muscle is the main insulin-sensitive tissue for postprandial
glucose disposal and for the oxidation of glucose- and lipid-based fuels
at rest and during exercise [1,2]. Skeletal muscle is also a site of in-
sulin resistance in type 2 diabetes [3,4]. Accordingly, skeletal muscle
exerts profound effects on whole-body substrate dynamics, as well as
playing a vital role in energy expenditure [5]. Type 2 diabetes shares
many features of “accelerated aging” including insulin resistance,
defective oxidative metabolism/mitochondrial function, and loss of
muscle mass [6]. Thus, targeting the transcriptional machinery to
maintain functional and metabolic properties of skeletal muscle may
prevent or delay insulin resistance and type 2 diabetes.
Several distinct sets of transcription factors have been classiﬁed for a
role in skeletal muscle atrophy, glucose metabolism, lipid metabolism,
myogenesis, angiogenesis, and mitochondrial biogenesis [7,8].
Notably, forkhead box proteins (FOXO), a family of transcription factors
with FOXO1, FOXO3, FOXO4, and FOXO6 expressed in skeletal muscle,
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standing the role of FOXO isoforms in the regulation of insulin-
stimulated gene expression and networks involved in substrate
metabolism, mitochondrial function, and growth may provide insights
into mechanisms controlling skeletal muscle plasticity in health and
disease.
Overexpression of FOXO1 increases the percentage of fast twitch
muscle ﬁbers and decreases muscle size [11]. This phenotype is
mirrored in skeletal muscle transiently expressing constitutively
active FOXO3 [12,13]. Inhibiting transcriptional activity of both
FOXO1 and FOXO3 in skeletal muscle utilizing a FOXO construct
lacking a transactivation domain (FOXOdn) increases ﬁber cross
sectional area and myotube diameter in oxidative soleus muscle and
glycolytic tibialis anterior muscle [14,15]. Skeletal muscle-speciﬁc
simultaneous deletion of FOXO1e3 isoforms, thereby avoiding any
compensatory increase in other isoforms, attenuates anabolic
signaling through Akt, and increases proteasomal degradation
without affecting autophagic signaling [16]. Conversely, as the FOXO
family is required for the induction of several atrophy-related genes,ska Institutet, Stockholm, Sweden 2Department of Molecular Medicine and Surgery,
isk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical
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Table 1 e Primer sequences.
Gene Forward primer Reverse primer
Foxo1 CTGCAGATCCCGTAAGACG GGTCACCGGTGTCTAAGGAG
Foxo3 GGAAGGGAGGAGGAGGAATG CTCGGCTCCTTCCCTTCAG
Ccl2 AGCCAACTCTCACTGAAGCC TTCTTGGGGTCAGCACAGAC
Ccl7 CCACCATGAGGATCTCTGCC ATAGCCTCCTCGACCCACTT
Ccl8 TTTGCCTGCTGCTCATAGCT TGTGAAGGTTCAAGGCTGCA
Cxcl9 ACCTCAAACAGTTTGCCCCA ACGACGACTTTGGGGTGTTT
Cd68 AAGGTCCAGGGAGGTTGTGA ATGAATGTCCACTGTGCTGC
Cd48 CTCGGGACCTTTCCCCAAAA ACTAGCCAAGTTGCAGTCCA
Itgax CCAGCCAGAGGATTTCAGCAT CTGCAGGTGTGAAGTGAACAG
Cd3g ACTGTAGCCCAGACAAATAAAGC TGCCCAGATTCCATGTGTTTT
Ncr1 GAGCCAGAGGATCAACACTG ATGGCTTTGGTCTCTCCAAGG
Ly6c ACCCTTCTCTGAGGATGGACA GCTGGGCAGGAAGTCTCAAT
Tbp CCTTGTACCCTTCACCAATGAC ACAGCCAAGATTCACGGTAGA
Original Articledeletion of FOXO1e3 isoforms in skeletal muscle prevents the
decline in muscle mass and force in response to fasting and
denervation [17]. Collectively, these studies highlight a role for FOXO
in skeletal muscle plasticity.
FOXO proteins play a role in the regulation of energy metabolism [10].
Perturbations that increase oxidative metabolism, including starvation
and exercise, increase FOXO1 and FOXO3 protein abundance [18,19],
thereby associating the regulation of lipid metabolism with FOXO1/3
expression. Overexpression of FOXO1 in C2C12 myotubes increases
protein abundance of fatty acid transporter protein CD36 [20] and li-
poprotein lipase [19], and concomitantly decreases PDK4 and glycogen
synthesis [20], further supporting a role for FOXO1 in oxidative
metabolism. Conversely, in vivo ablation of FOXO1e4 does not alter
muscle glycogen content [17]. Skeletal muscle-speciﬁc over-
expression of FOXO1 in transgenic mice impairs glucose tolerance
[11], without altering fed glucose levels [11,21], implicating a role in
glucose homeostasis. Nevertheless, the role of speciﬁc FOXO isoforms
in metabolic homeostasis in skeletal muscle remains unclear. Of in-
terest, glucocorticoids, anti-inﬂammatory hormones that regulate the
switch from glycolytic to oxidative metabolism [22], upregulate FOXO1/
3 expression in skeletal muscle [23,24]. Thus, FOXO may play a
transcriptional role in skeletal muscle to inﬂuence “immunometabo-
lism” by altering processes governing immunological and metabolic
processes [25].
The aim of this study was to elucidate the role of FOXO1 and
FOXO3 transcriptional networks in skeletal muscle on glucose
metabolism. This was achieved by transiently overexpressing FOXO
constructs lacking the transactivation domain in mouse tibialis
anterior muscle and determining the in vivo effects on glucose
uptake, glycogen content, transcriptomic proﬁles, and relevant
signaling pathways.
2. MATERIALS AND METHODS
2.1. Animal studies
Animal experiments were approved by the Regional Animal Ethical
Committee (Stockholm, Sweden). Male C57BL/6J mice (30 week old)
were purchased from Janvier (France). Mice received ad libitum
access to water and standard rodent chow (Lantmännen, Sweden),
and were housed on a 12 h light/dark cycle. Following one week of
acclimatization, tibialis anterior muscle was transfected with either a
control plasmid or plasmid encoding for FOXO1dn or FOXO3dn
(Invitrogen GeneArt, ThermoFisher Scientiﬁc, Rockford, IL) by elec-
troporation as described [26]. One week post-electroporation, mice
were fasted for 4 h, and glucose uptake was measured in vivo using
a modiﬁed oral glucose tolerance test as described [26]. Brieﬂy, 4 h
fasted mice received a glucose gavage (3 g/kg), and 2-[3H]deoxy-D-
glucose (100 ml of saline/animal, 1 mCi/ml) was administered
intraperitoneally. Mice were anesthetized with an intraperitoneal
Avertin injection, 120 min after the start of the experiment, and
electroporated tibialis anterior muscle was removed and rapidly
frozen in liquid nitrogen. Glycogen content was determined using a
commercially available kit (ab65620, Abcam, Cambridge, UK). A
schematic representation of the animal experiments is shown in
Figure S1.
2.2. Construct design
The FOXO1dn sequence was the same as previously described [27]
consisting of amino acids 1e256. The FOXO3dn sequence was
designed by aligning the murine amino acid sequence with a previ-
ously described dominant negative human sequence [28] yielding the80 MOLECULAR METABOLISM 20 (2019) 79e88  2018 The Authors. Published by Elsevier G
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sequences obtained were optimized and converted to nucleotide se-
quences by GeneArt, and plasmids including LacZ encoding control
vector were synthesized by GeneArt, (Invitrogen GeneArt, Thermo-
Fisher Scientiﬁc). A schematic representation of the construct design
can be found in Figure S1.
2.3. RNA extraction and gene expression analysis
qPCR analysis was performed on total RNA from skeletal muscle of
mice that underwent an oral glucose tolerance test. RNA was extracted
with Trizol (Life Technologies). Total RNA concentration was quantiﬁed
spectrophotometrically (NanoDrop ND-1000 Spectrophotometer,
ThermoFisher Scientiﬁc). RNA was reverse-transcribed to cDNA using
the High Capacity cDNA RT kit (ThermoFisher Scientiﬁc) and gene
expression was determined by real-time PCR utilizing SYBR Green
reagents (Life Technologies, ThermoFisher Scientiﬁc). Gene expression
was quantiﬁed with the DDCt method using Tbp as control. Primer
sequences are presented in Table 1. Microarray analysis was per-
formed on total RNA extracted from electroporated muscle utilizing the
EZ RNA extraction kit and hybridized to an Affymetrix Mouse Gene 2.1
ST array (ThermoFisher Scientiﬁc) at the core facility for Bioinformatics
and Expression Analysis (BEA) at Karolinska Institutet. The microarray
data are publicly available at Gene Expression Omnibus (GEO acces-
sion: GSE105778).
2.4. Immunoblot analysis
Western blot analysis was performed as described from skeletal
muscle of mice that underwent an oral glucose tolerance test [26].
Ponceau staining was used to conﬁrm equal protein loading [29]. The
following antibodies used for immunoblot analysis were purchased
from Cell Signaling Technology (Beverly, MA): Akt (#9272), p-Akt
Thr308 (#4056), p-Akt Ser473 (#9271), GSK3b (#9315), p-GSK3b Ser9
(#9323), GS (#3839), p-GS Ser641 (#3891), mTOR (#2983), p-mTOR
Ser2448 (#5536), 4EBP1 (#9644), p-4EBP1 Thr37/46 (#2855), p-p70S6K
Thr389 and Thr421/Ser424 (#2708), p70S6K (#9205), p-STAT1 Tyr701
(#9171), STAT1 (#9172). The following antibodies were purchased
from Abcam (Cambridge, UK): total OXPHOS Rodent WB Antibody
Cocktail (ab110413), FOXO1 (ab12161), and FOXO3 (ab47409). Anti-
bodies against GLUT4 (#07-1404, Millipore, Darmstadt, Germany) and
Hexokinase 2 (kindly provided by Oluf Pedersen, University of
Copenhagen) were used. Appropriate secondary mouse or rabbit an-
tibodies were purchased from Bio-Rad. The immunoreactive proteins
were quantiﬁed densitometrically utilizing Quantity One Software (Bio-
Rad).mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.5. Statistical analysis
CEL ﬁles from the microarray experiment on platform Affymetrix
MoGene-2_1-st were collected for 41345 probesets and 24 samples
(6 paired samples with control and FOXO1dn overexpression construct,
6 paired samples with control and FOXO3dn overexpression construct).
Data was analyzed in R (version 3.4.4) [30] utilizing the oligo package
for the robust multi-array average (RMA) normalization using the oligo
library from Bioconductor [31] on the pd.mogene.2.1.st library [32].
Transcripts with miRNA, pseudogene, and predicted genes, were
ﬁltered out from the dataset since a single probe was overlapping with
one or more of these annotated regions, reducing the probeset to
22,557. Probesets belonging to multiple genes were collapsed by
using collapseRows function from WGCNA R package [33]. This pro-
cedure resulted in 20,295 unique genes for downstream analysis.
Differential expression analysis was performed with limma [34], and
sample pairing was deﬁned with duplicateCorrelation, using the model
design ‘yw 0 þ plasmid’, where plasmid represented whether mice
were electroporated with control or FOXO construct. Transcriptome
data was visualized using the factoextra and ggplot2 package [35].
Gene set enrichment analysis (GSEA) was performed with cluster-
Proﬁler [36], with the minimum gene set size 10, and 1,000,000
permutations for GSEA. Inﬂammatory cell signature deconvolution
analysis was performed using the CIBERSOFT framework [37], using
murine immune cell signatures [38].
Glucose uptake, qPCR and western blot data were analyzed in
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA) with a
paired student t-test. The signiﬁcance threshold was deﬁned at
p < 0.05, except for the transcriptomic analysis, where signiﬁcance
was deﬁned at a multiple testing adjusted p-value< 0.05 and absolute
log2 fold-change > 1.
3. RESULTS
3.1. Glucose uptake and glycogen content
Electroporation of tibialis anterior muscle with either FOXO1dn or
FOXO3dn constructs (Figure S1) led to efﬁcient overexpression of each
respective protein as detected by western blot analysis (Figure 1A).
FOXO1dn and FOXO3dn electroporation led to changes in gene
expression of canonical FOXO responsive genes [17] (Figure S2A,B).
FOXO1dn transfection decreased endogenous FOXO1 expression 50%
(p < 0.01) and endogenous FOXO3 expression 20% (p < 0.05), while
FOXO3dn transfection was without effect on either endogenous iso-
forms (Figure 1B). Overexpression of either FOXO1dn (Figure 1C) or
FOXO3dn (Figure 1D) construct decreased in vivo glucose uptake
during a glucose tolerance test, as compared to the contralateral
control muscle (35%, p< 0.001 and 20%, p< 0.05, for FOXO1dn and
FOXO3dn, respectively). Intramuscular glycogen content was unaltered
by overexpression of the FOXO1dn construct (Figure 1E) and decreased
20% by overexpression of the FOXO3dn construct (p < 0.05,
Figure 1F).
3.2. Transcriptomic analysis
Transcriptomic and principal component analysis revealed that the
insulin-stimulated gene expression proﬁles are clearly separated
between FOXO1dn transfected and control plasmid transfected
muscle (Figure 2A). Conversely, the separation of gene expression
proﬁles between FOXO3dn transfected and control plasmid trans-
fected muscle was less obvious (Figure 2B). FOXO1dn transfection
downregulated the expression of 25 genes and upregulated the
expression of 382 genes (Figure 2C), while FOXO3dn transfection
downregulated the expression of 4 genes and upregulated theMOLECULAR METABOLISM 20 (2019) 79e88  2018 The Authors. Published by Elsevier GmbH. This is a
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in Supplementary Table 1. Gene set enrichment analysis of the
FOXO1dn- or FOXO3dn-transfected skeletal muscle transcriptome
revealed that the top positively enriched gene ontologies were
associated with inﬂammatory processes, while the top negatively
enriched gene ontologies were associated with energy metabolism
(Figure 2E, Supplementary Table 2). The overall overlap of enriched
gene ontologies by each construct was substantial, with 884 com-
mon, and 277 unique for FOXO1dn and 185 unique for FOXO3dn
transfection (Figure 2F). KEGG pathway GSEA of FOXO1dn- or
FOXO3dn-transfected skeletal muscle revealed a similar response on
the transcriptome between the two constructs (Figure S3A,
Supplementary Table 3), and the overall overlap of KEGG pathways
was also substantial (Figure S3B). The overlap was 309 unique genes
for FOXO1, 26 for FOXO3, and 98 in common (Figure 2G). The overlap
of differentially expressed genes for each construct and publicly
available data of chromatin immunoprecipitation data from FOXO1
[39] and FOXO3 [40] was 2 and 6 respectively (Figure S4A,B).
3.3. Protein abundance of GLUT4 and mitochondrial oxidative
phosphorylation (OXPHOS) complexes
GLUT4 protein abundance was decreased in response to over-
expression of either the FOXO1dn (40%, p < 0.05; Figure 3A,E) or
the FOXO3dn (10%, p < 0.05; Figure 3B,E) construct, while HK2
protein content was unaffected (Figure 3A,B,E). Overexpression of
either the FOXO1dn or the FOXO3dn construct attenuated the
abundance of several proteins involved in oxidative phosphorylation.
FOXO1dn overexpression decreased protein abundance of complex
IV and complex V (50%, p < 0.05 and 20%, p < 0.05 respectively;
Figure 3C,E), and FOXO3dn overexpression decreased protein
abundance of complex II, III, and IV (40%, p< 0.001; 10%, p< 0.05;
and 30%, p < 0.01 respectively; Figure 3D,E). Gene expression of
complex IV subunits was decreased in 8 and increased in 2 out of 24
subunits measured after FOXO1dn overexpression, while FOXO3dn
overexpression decreased the expression of only 1 subunit
(Figure S4A,B).
3.4. Akt and mTOR signaling
Overexpression of the FOXO1dn construct increased Akt signaling in
skeletal muscle, as evidenced by increased Akt protein (140%,
p < 0.001), p-Akt Ser473 (720%, p < 0.05) and p-Akt Thr308 (570%,
p < 0.005; Figure 4A,E), whereas overexpression of the FOXO3dn
construct was without effect (Figure 4B,F). Overexpression of the
FOXO3dn construct decreased glycogen synthase protein abundance
(20%, p < 0.01), without altering glycogen synthase phosphorylation
(Figure 4B,F), whereas overexpression of the FOXO1dn construct had
no effect (Figure 4A). GSK3b phosphorylation was decreased by
FOXO1dn transfection (20%, p < 0.05), while FOXO3dn transfection
decreased GSK3b total protein content (20%, p < 0.01)
(Figure 4A,B,E,F).
Skeletal muscle overexpression of either the FOXO1dn or FOXO3dn
construct increased mTOR protein abundance (170% and 190%,
p < 0.05), while phosphorylation was only increased by FOXO1dn
transfection (500%, p < 0.0005) (Figure 4CeF). The mTOR target,
p70S6K, was modestly decreased (7%, p < 0.05) in response to
FOXO1dn transfection (Figure 4C,E), and unaltered in response to
FOXO3dn transfection (Figure 4D,F), while p70S6K phosphorylation
was increased (420%, p < 0.05 and 300%, p < 0.05 respectively;
Figure 4CeF). Total 4E-BP1 protein abundance decreased (30%,
p < 0.005) only in response to the FOXO3dn transfection
(Figure 4D,F).n open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 81
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Figure 1: In vivo glucose uptake and glycogen content in tibialis anterior skeletal muscle overexpressing FOXO1dn or FOXO3dn constructs. (A) Representative western
blot of FOXO1dn and FOXO3dn construct overexpression. (B) Endogenous FOXO1 and FOXO3 expression 7 days following electroporation with either FOXO1dn or FOXO3dn
constructs detected by qPCR. (C) In vivo glucose uptake during a 2-h oral glucose tolerance test (3 g/kg) measured by accumulation of 3H-deoxyglucose in skeletal muscle after
FOXO1dn versus respective contralateral control leg, or (D) FOXO3dn versus respective contralateral leg. (E) Glycogen content in skeletal muscle after FOXO1dn versus respective
contralateral control leg, or (F) FOXO3dn versus contralateral leg. Data are mean or individual fold changes  SEM for paired muscle samples. n ¼ 12 mice per construct,
*p < 0.05 and **p < 0.01.
Original Article3.5. Inﬂammatory signaling
Protein content of STAT1 was increased in skeletal muscle in response
to overexpression of either the FOXO1dn or FOXO3dn construct (720%,
p < 0.005 and 220%, p < 0.05 respectively; Figure 5AeC), whereas
STAT1 phosphorylation was increased only in response to the FOX-
O1dn transfection (820%, p < 0.01) (Figure 5A,C). Gene expression of
the chemokines Ccl2, Ccl7, Cxcl9, and Ccl8, were robustly upregulated
in response to overexpression of either construct (Figure 5D). Markers
of immune cells, including Cd68, Cd48, Itgax, Cd3g, Ncr1, Itgam, and82 MOLECULAR METABOLISM 20 (2019) 79e88  2018 The Authors. Published by Elsevier G
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transfection increased Cd68 (200%, p < 0.01), Itgam (170%,
p < 0.05) and Ly6c (130%, p < 0.05) mRNA expression (Figure 5E).
Immune cell signature analysis showed that the M1 macrophages
were the main signature enriched in response to either FOXO1dn or
FOXO3dn transfection (Figure S6A,B). Moreover, the immune cell
signatures were efﬁciently separated between FOXO1dn and FOXO3dn
transfected samples from the respective control samples using prin-
cipal component analysis (Figure S6C,D).mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.comen from ClinicalKey.com by Elsevier on November 01, 2019.
opyright ©2019. Elsevier Inc. All rights reserved.
Figure 2: Transcriptomic analysis of tibialis anterior muscle after FOXOdn
overexpression. (A) Principal component analysis of transcriptomic data of tibialis
anterior muscle after FOXO1dn or (B) FOXO3dn overexpression. (C) Volcano plot
showing changes in gene expression after FOXO1dn or (D) FOXO3dn overexpression.
Dashed lines indicate value cutoff at multiple testing adjusted p < 0.05 and fold
change of at least 1 logFC. (E) Overlap of FOXO1 and FOXO3 GSEA, showing
MOLECULAR METABOLISM 20 (2019) 79e88  2018 The Authors. Published by Elsevier GmbH. This is a
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FOXO transcription factors regulate skeletal muscle mass and ﬁber
type characteristics [9,10]. Furthermore, FOXO proteins are essential
for a wide range of metabolic functions, including the control of car-
bohydrate and lipid oxidation in skeletal muscle during fasting [18] or
high fat feeding [41]. Here we provide evidence that overexpression of
either a FOXO1dn or FOXO3dn construct in skeletal muscle attenuates
glucose uptake. FOXO transcriptional regulation of glucose uptake is
likely to involve several mechanisms. We found FOXO1dn or FOXO3dn
transfection decreased GLUT4 protein abundance, which may account
for the attenuation of glucose uptake [42]. The reduction in GLUT4
protein may occur from the regulation of PPARg1 or PPARg2 promoter
binding [43], or by a direct interaction between FOXO and the GLUT4
promoter [44]. Skeletal muscle speciﬁc triple deletion of FOXO1,
FOXO,3 and FOXO4, does not affect glycogen content [17], implying
that the binding sites of FOXO proteins might be relevant for other
transcription factors that regulate metabolism. However, we found
overexpression of FOXO3dn, but not FOXO1dn, decreased intramus-
cular glycogen content. Thus, our results indicate that glucose storage
is under the regulation of FOXO3 transcriptional activity and implies
specialized roles of FOXO isoforms in the control of glucose uptake and
metabolism.
FOXO proteins regulate energy homeostasis through the control of
glucose metabolism and mitochondrial respiration [10]. Liver speciﬁc
deletion of FOXO1 restores mitochondrial respiration in insulin resistant
mice [45], while in vitro expression of constitutively active FOXO3
reduces mitochondrial respiration and respiratory chain complex pro-
teins [46]. FOXO1 activation in C2C12 skeletal muscle cells increases
fatty acid uptake and oxidation and drives the expression of genes
involved in lipid metabolism [20]. This ﬁnding suggests that inactiva-
tion of FOXO1 may contribute to the accumulation of intramuscular
lipids and insulin resistance. Here we found that a transient inhibition
of FOXO transcriptional activity decreased the abundance of mito-
chondrial proteins in skeletal muscle. Thus, the reduction in glucose
uptake in skeletal muscle overexpressing FOXO1dn or FOXO3dn may
arise from an accumulation of intramuscular lipids or metabolic in-
termediates due to attenuated mitochondrial respiration. These
changes may occur by a direct or indirect gene regulatory mechanism,
or secondarily from reduced glucose uptake. Furthermore, the
decreased GLUT4 protein content, combined with the decreased
abundance of mitochondrial OXPHOS complexes, may account for the
reduction in glucose uptake in skeletal muscle. Skeletal muscle
glycogen content and glycogen synthase protein content, was
decreased only after FOXO3dn transfection, indicating that FOXO3
plays a role in regulating glucose storage. The decrease in OXPHOS
complexes and GLUT4 after FOXO1dn transfection are insufﬁcient to
affect skeletal muscle glycogen content as observed after FOXO3dn
transfection.
We performed a transcriptomic analysis to identify distinct signa-
tures of gene expression proﬁles inﬂuenced by inactivation of FOXO1
or FOXO3 in skeletal muscle. The microarray analysis was validated
by qPCR (Figure 5D,E). Canonical FOXO target genes [17] were
changed by FOXOdn transfection (Figure S2A,B), indicating that thebiological process (BP) gene ontologies, with the triangle showing negative or positive
enrichment, and the shade indicating FDR. (F) Overlap of signiﬁcantly enriched BP gene
ontologies after FOXO1dn or FOXO3dn overexpression. (G) Overlap of differentially
expressed genes in tibialis anterior muscle after FOXO1dn or FOXO3dn overexpression.
n ¼ 6 mice, all indicated pathways are signiﬁcant at FDR < 0.05.
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Original Articleinhibition of FOXO transcriptional activity was successful. FOXO1dn
transfection had more robust effects on FOXO target genes as
compared with FOXO3dn, reﬂecting the results from the differential
expression analysis. Our transcriptome analysis revealed that the
overlap of differentially expressed genes induced by the FOXO1dn
and FOXO3dn overexpression was w10% and 90% respectively.
The pathways modulated by the FOXO1dn and FOXO3dn trans-
fections were remarkably similar, with w80% being shared. The
transcriptomic changes observed after FOXOdn transfections appear
to be secondary, as there was little overlap with publicly available
chromatin immunoprecipitation data [39,40]. This would suggest
that the function of FOXO proteins on metabolism and inﬂammation
is to coordinate the gene expression response to environmental
stimuli.
Overexpression of FOXO1dn or FOXO3dn constructs reduces the
expression of genes controlling oxidative phosphorylation and fatty
acid metabolism. These results were consistent with changes in the
abundance of mitochondrial complex proteins, and decreases in the
expression of genes encoding mitochondrial complex proteins,
implying that the changes are due to transcriptional, rather than
posttranslational effects. Moreover, we found the Akt signaling
pathway as well as several inﬂammatory pathways were altered inFigure 3: FOXOdn transfection effects on abundance of proteins involved in glucose
GLUT4 and Hexokinase 2 (HK2) protein content in skeletal muscle after FOXO1dn transfectio
oxidative phosphorylation chain enzymes, complex IeV, following FOXO1dn transfection,
mitochondrial respiratory chain complex protein abundance. Data are mean  SEM. n ¼
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Thus, inactivation of FOXO signaling gives rise to an immunometab-
olism gene signature that is characteristic of obesity-induced insulin
resistant states [47,48]. Inﬂammatory signaling alters lipid metabolism
in liver, adipose tissue, skeletal muscle, and macrophages in the
context of infection, diabetes, and atherosclerosis.
FOXOdn transfection attenuated skeletal muscle glucose uptake,
concomitant with increased Akt signaling, as revealed by our protein
content and phosphorylation analysis. Additionally, FOXOdn trans-
fection increased Akt signaling, consistent with our ﬁnding of
increased mTOR protein content and p70S6K phosphorylation after
transfection with either FOXO1dn or FOXO3dn. Previous studies
establish that FOXO proteins regulate insulin sensitivity in liver [49,50],
skeletal muscle [51], and adipose tissue [52]. Furthermore, FOXO1 has
been shown to increase Akt phosphorylation through tribble 3, a
modulator of Akt activity, by suppressing its promotor activity [50], and
stimulate phosphatase activity in cardiomyocytes [53]. Here we show
that inhibition of FOXO1 transcriptional activity increased Akt phos-
phorylation, indicating that FOXO transcription binding sites rather than
FOXO proteins are likely to mediate tribble 3 or phosphatase activity.
Thus, the two contrasting observations of decreased glucose uptake
(due to decreased protein content of GLUT4 and energy metabolizingmetabolism and oxidative phosphorylation in skeletal muscle. (A) Quantiﬁcation of
n, or (B) FOXO3dn transfection. (C) Quantiﬁcation of protein abundance of mitochondrial
or (D) FOXO3dn transfection. (E) Representative western blots of GLUT4, HK2 and the
11 mice, *p < 0.05 and **p < 0.01.
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Figure 4: Changes in total protein abundance and phosphorylation of signaling pathways in tibialis anterior muscle after FOXO1dn or FOXO3dn overexpression. (A)
Quantiﬁcation of protein abundance and phosphorylation of Akt signaling in tibialis anterior skeletal muscle after FOXO1dn transfection, or (B) FOXO3dn transfection. (C)
Quantiﬁcation of protein abundance and phosphorylation of mTOR, and protein synthesis signaling following FOXO1dn transfection, or (D) FOXO3dn transfection. (E) Representative
western blots of the studied signaling cascades for FOXO1dn transfection, or (F) FOXO3dn transfection. Data are mean  SEM. n ¼ 11 mice, *p < 0.05 and **p < 0.01.enzymes), and increased Akt phosphorylation (due to changes in Akt
modulating enzymes) might be due independent and parallel
mechanisms.
FOXO proteins regulate inﬂammatory cell function [54]. FOXO1 or
FOXO3 deﬁciency in vivo leads to immune cell activation and prolif-
eration [55,56]. Our GSEA indicates that several inﬂammatory signaling
pathways are enriched after either FOXO1dn or FOXO3dn transfection.
This observation was biochemically validated by measuring changes in
chemokine expression, STAT1 signaling, and immune cell markers.
Moreover, our data suggest that FOXO1 and FOXO3 transcriptional
activity is necessary for suppression of inﬂammatory signaling, as
STAT1 total protein content, expression of chemoattractants, andMOLECULAR METABOLISM 20 (2019) 79e88  2018 The Authors. Published by Elsevier GmbH. This is a
www.molecularmetabolism.com
Downloaded for Anonymous User (n/a) at BS - University of Co
For personal use only. No other uses without permismarkers of immune cells were robustly increased in skeletal muscle
overexpressing FOXO1dn or FOXO3dn constructs. The increased
STAT1 protein content after FOXO1dn or FOXO3dn transfection sug-
gests that interferon g and interferon b signaling was increased after
transfection [57], in accordance with the predictions from the pathway
analysis. The increased expression of chemokines is concurrent with
increased expression of immune cell markers, conﬁrming that FOXO
transcriptional activity is involved in the recruitment of inﬂammatory
cells within skeletal muscle. However, as the electroporation proced-
ure could cause early and transient inﬂammation [58], FOXO tran-
scriptional activity might be necessary for suppressing an initial
inﬂammatory insult. Muscle inﬂammation regulates glucose uptaken open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 85
penhagen from ClinicalKey.com by Elsevier on November 01, 2019.
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Figure 5: Effects of FOXOdn overexpression on inﬂammatory signaling pathways in tibialis anterior muscle. (A) Quantiﬁcation of STAT1 protein content and phos-
phorylation after FOXO1dn or (B) FOXO3dn electroporation in tibialis anterior muscle. (C) Representative western blots of STAT1 protein content and phosphorylation after FOXO1dn
or FOXO3dn overexpression. (D) Gene expression analysis of chemokine genes after FOXO1dn or FOXO3dn overexpression. (E) Gene expression of key immune cell markers after
FOXO1dn or FOXO3dn overexpression. Data are mean  SEM. n ¼ 11 mice. *p < 0.05 and **p < 0.01.
Original Articleand metabolism [59,60], raising the possibility that tissue inﬂammation
occurs synergistically with changes in mitochondrial and GLUT4 pro-
tein levels to regulate glucose handling after FOXOdn transfection. The
possibility that FOXOdn transfection might increase systemic inﬂam-
mation through secreted chemokines seems implausible given that the
control transfected leg showed lower levels of inﬂammatory signaling.
Future studies are warranted to establish the mechanism by which
FOXO transcriptional activity governs inﬂammation in skeletal muscle,
and whether FOXO regulation of inﬂammatory processes is indepen-
dent of glucose and energy homeostasis.86 MOLECULAR METABOLISM 20 (2019) 79e88  2018 The Authors. Published by Elsevier G
Downloaded for Anonymous User (n/a) at BS - University of Copenhag
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including skeletal muscle insulin resistance, exercise, and atro-
phy, highlighting the role of FOXO as a central transcriptional
regulator of maintenance of skeletal muscle energy homeostasis
[9,10,12]. Our study reveals that FOXO1 and FOXO3 transcrip-
tional activity is necessary for the regulation of glucose handling
and control of inﬂammatory signaling in mature skeletal muscle. A
further understanding of the role of FOXO in the control of
metabolic and inﬂammatory events in skeletal muscle may
identify pathways governing “immunometabolic” networksmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.comen from ClinicalKey.com by Elsevier on November 01, 2019.
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involved in several pathophysiological conditions affecting skeletal
muscle function.
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